Business Context and Reporting Period
This summary covers the Form 10-Q filed by Acxiom Corporation (Note: The input metadata incorrectly lists "Liveramp Holdings, Inc."; the filing text identifies the registrant as Acxiom Corporation) for the quarterly period ended September 30, 2001. Acxiom is a provider of customer data integration and information management services. The reporting period reflects the second quarter of fiscal year 2002.
Key Financial Metrics
| Metric | Q3 2001 (3 Months) | Q3 2000 (3 Months) | YTD 2001 (6 Months) | YTD 2000 (6 Months) |
|---|---|---|---|---|
| Revenue | $215.2 million | $263.9 million | $420.2 million | $503.4 million |
| Net Earnings (Loss) | $7.0 million | $23.6 million | $(56.6) million | $8.8 million |
| Operating Income (Loss) | $20.0 million | $45.3 million | $(72.8) million | $79.5 million |
| Diluted EPS | $0.08 | $0.25 | $(0.63) | $0.11 |
| Cash & Equivalents | $9.1 million | N/A (Balance Sheet Comparison) | ||
| Working Capital | $103.0 million | |||
| Total Debt (Current + Long-term) | $499.3 million | N/A (Balance Sheet Comparison) | ||
| Debt-to-Capital Ratio | 49% | N/A (Balance Sheet Comparison) |
Note: YTD 2000 Net Earnings includes a $37.5 million cumulative effect of a change in accounting principle.
Material Changes vs. Prior Period
- Revenue Decline: Revenue decreased 18% year-over-year for the quarter and 17% for the six months. Management attributes this to a general economic slowdown and changes in revenue recognition for software licenses (shifting to subscription models).
- Restructuring Charges: The company recorded $45.3 million in nonrecurring charges during the six-month period. This included a $31.2 million loss on a sale-leaseback of computer equipment, $8.3 million in severance costs for a 7% workforce reduction, and other impairment charges.
- Operating Loss: While the quarter ended September 30, 2001, was profitable ($20.0M operating income), the six-month period resulted in a significant operating loss of $72.8 million, primarily driven by the restructuring charges and accelerated depreciation recorded in the first quarter.
- Debt Increase: Total debt increased significantly due to a new $64.2 million term loan used to settle equity forward contracts and increased utilization of the revolving credit facility.
Guidance, Outlook, and Risks
- Q4 2001 Guidance: Revenue expected between $220 million and $225 million; EPS expected between $0.12 and $0.14.
- Fiscal 2002 Guidance: Revenue expected between $865 million and $880 million (excluding $30-$40 million of deferred hardware revenue). Adjusted EPS expected between $0.28 and $0.31.
- Long-Term Outlook: Revenue growth of approximately 20% and EPS of $0.65 to $0.75 expected for fiscal 2003.
- Key Risks:
- Persistence of the economic slowdown and potential worsening conditions following the September 11 attacks.
- Lengthening sales cycles and potential contract cancellations.
- Reliance on credit availability; the revolving credit facility was amended to reduce capacity to $265 million and requires collateralization of assets.
- Regulatory changes regarding data collection and privacy.
- Accounting Changes: The company early-adopted SFAS No. 142, discontinuing goodwill amortization effective April 1, 2001, which improved reported earnings by approximately $2 million for the quarter.
Investor Verification Checklist
- Restructuring Execution: Verify the actual cash outflow for severance and lease terminations against the $45.3 million accrual to ensure no further unexpected charges.
- Debt Covenants: Confirm continued compliance with the amended revolving credit facility covenants, specifically regarding collateral agreements and the $265 million cap.
- Revenue Recognition: Scrutinize the impact of the shift to subscription-based revenue recognition for AbiliTec software on future quarterly comparability.
- Hardware Sales Deferral: Monitor the recognition of the $20+ million in hardware sales deferred over contract terms to ensure they materialize as projected.
- Goodwill Impairment: Review the annual goodwill impairment testing results required under SFAS No. 142, as future charges could impact earnings.